ONCOMYX THERAPEUTICS
OncoMyx Therapeutics develops oncolytic immunotherapies called myxoma (MYXV) to assist in creating an immune response and treat cancer. Its myxoma virus (MYXV) platform targets hematologic and solid tumors with a unique oncolytic virus called myxoma and a novel patented systemic delivery approach which can be carried systemically by human leukocytes where it can then infect tumor cells. The company was founded in 2018 and is headquartered in Phoenix, Arizona.
ONCOMYX THERAPEUTICS
Industry:
Biotechnology Health Diagnostics Medical Therapeutics
Founded:
2018-01-01
Address:
Phoenix, Arizona, United States
Country:
United States
Website Url:
http://www.oncomyx.com
Total Employee:
11+
Status:
Active
Total Funding:
50 M USD
Current Advisors List
Investors List
Delos Capital
Delos Capital investment in Series B - OncoMyx Therapeutics
Madison Partners
Madison Partners investment in Series B - OncoMyx Therapeutics
Xeraya Capital
Xeraya Capital investment in Series B - OncoMyx Therapeutics
City Hill Ventures
City Hill Ventures investment in Series B - OncoMyx Therapeutics
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series B - OncoMyx Therapeutics
Lumira Ventures
Lumira Ventures investment in Series B - OncoMyx Therapeutics
B Capital Group
B Capital Group investment in Series B - OncoMyx Therapeutics
Korea Investment Partners
Korea Investment Partners investment in Series B - OncoMyx Therapeutics
LYZZ Capital
LYZZ Capital investment in Series B - OncoMyx Therapeutics
Official Site Inspections
http://www.oncomyx.com Semrush global rank: 4.39 M Semrush visits lastest month: 2.55 K
- Host name: 202.88.225.35.bc.googleusercontent.com
- IP address: 35.225.88.202
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
